Grifols S.A. ADR

Grifols S.A. ADR is a healthcare and biotechnology asset representing Grifols’ U.S. depositary shares. Grifols is a global specialty plasma therapeutics company focused on the research, development, manufacturing, and distribution of plasma-derived medicines and related biopharmaceutical products. Its core activities span biopharma, diagnostic solutions, bio supplies, and other healthcare services, supporting treatment areas such as immunodeficiencies, bleeding disorders, and hospital-based care. The company also provides diagnostic systems, reagents, and products used in transfusion medicine and clinical laboratories, making it an important supplier to hospitals, blood centers, and healthcare providers. Grifols S.A. ADR gives investors access to a multinational healthcare business whose products and services are deeply embedded in the plasma medicine and diagnostics market.

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Mr. Jose Ignacio Abia Buenache

Employees

25,000

Headquarters

Barcelona, Spain

Website

www.grifols.com